Navigation Links
Aspirin as Effective as Warfarin for Heart Failure: Study
Date:5/2/2012

WEDNESDAY, May 2 (HealthDay News) -- Aspirin is just as effective as the blood-thinner warfarin in preventing stroke and death in heart failure patients with a normal heart rhythm, a landmark study indicates.

Although the two treatments are equally effective, researchers from Columbia University in New York City said their findings could prompt more doctors and patients to choose aspirin because it is much cheaper.

The 10-year study was the largest comparison of aspirin and warfarin (Coumadin) in the treatment of heart failure patients. In conducting the comparison, researchers followed more than 2,300 patients in 11 countries on three continents. Study participants were assigned randomly either to aspirin or warfarin, and neither the patient nor their doctor knew which medication each patient was taking.

The investigators found that the combined risk of death, stroke and cerebral hemorrhage during the study period was 7.47 percent for patients taking warfarin and 7.93 percent for patients taking aspirin -- a difference that is statistically insignificant.

Although patients taking warfarin had a nearly 50 percent lower risk for stroke than those taking aspirin, their risk for major bleeding was twice as high. As a result, the researchers argued that the benefits do not outweigh the risks. They noted, however, that taking warfarin for four years or more may be more effective at preventing stroke and death.

"With at least 6 million Americans -- and many more around the world -- suffering from heart failure, the results of the ... study will have a large public health impact," Dr. Walter Koroshetz, deputy director of the U.S. National Institute of Neurological Disorders and Stroke, said in a Columbia University news release. "Patients and their physicians now have critical information to help select the optimum treatment approach. The key decision will be whether to accept the increased risk of stroke with aspirin or the increased risk of primarily gastrointestinal hemorrhage [stomach bleeding] with warfarin."

Although the study, published in the May 3 issue of the New England Journal of Medicine, found aspirin and warfarin to be equally effective, the researchers noted that aspirin may be a more likely choice for doctors and patients.

Like warfarin, aspirin reduces the risk of stroke due to a clot or blockage. Aspirin, however, is cheaper and available over the counter. Warfarin also requires a strict dosing regimen, including regular blood tests to monitor patients' clotting levels.

"Since the overall risks and benefits are similar for aspirin and warfarin, the patient and his or her doctor are free to choose the treatment that best meets their particular medical needs," principal investigator, Dr. Shunichi Homma, associate chief of the cardiology division at New York-Presbyterian/Columbia and a professor of medicine at Columbia's College of Physicians and Surgeons in New York City, said in the news release. "However, given the convenience and low cost of aspirin, many may go this route."

More information

The U.S. National Heart, Lung, and Blood Institute has more about treatments for heart failure.

-- Mary Elizabeth Dallas

SOURCE: Columbia University, news release, May 2, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Report says new evidence could tip the balance in aspirin cancer prevention care
2. Can eradicating a common stomach bug make taking aspirin safer?
3. Aspirin may counteract potential trans fat-related stroke risk in older women
4. New hybrid NOSH aspirin as possible anti-cancer drug
5. Aspirin as Good as Plavix for Poor Leg Circulation: Study
6. Experimental Drug Might Beat Aspirin in Preventing Repeat Strokes: Study
7. Low-Dose Aspirin to Prevent First Heart Attack or Stroke? Not So Fast
8. Could Daily Aspirin Harm Seniors Eyes?
9. Low-Dose Aspirin After Lung Clot Could Prevent Recurrence
10. Preoperative aspirin therapy can benefit cardiac surgery patients
11. Daily Aspirin May Help Prevent Colon Cancer for Those at High Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin as Effective as Warfarin for Heart Failure: Study
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... More than ... Hep B United Philadelphia, and the Prevent Cancer Foundation held an event on National ... epidemic in the city of viral hepatitis, the leading cause of liver cancer. , ...
(Date:5/31/2016)... ... 2016 , ... St. Joseph Medical Center (SJMC) announced that ... enables physicians at SJMC’s two hospital campuses, downtown and in the Heights, to ... exchange. SJMC’s membership in the health information exchange underscores the hospital’s commitment to ...
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop first demonstrated its ... something that contractors should have at their disposal on a daily basis. , ... Director of Contractor Programs. , As a result, Metloop and CertainTeed entered ...
(Date:5/31/2016)... ... May 31, 2016 , ... Spartan Bioscience ... enables unprecedented portability and convenience. , The Cube is exceptionally small—it takes up ... the Cube fits easily into any space, whether in a hospital, doctor’s office, ...
(Date:5/31/2016)... ... ... Like jewels in a crown, the multiple awards presented to Fayez Spa confirm ... day spa and one of Canada’s few accredited 5 Star Spas! , The ... spa services with hair and beauty services and has resulted in creating ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... , May 31, 2016 Aloe ... in food, cosmetics and pharmaceuticals, with global volume to ... US$ 1.6 Bn. Demand for aloe vera ... and yogurts will continue its upward momentum in 2016 ... also boost positive sentiment on aloe vera, with wide-ranging ...
(Date:5/31/2016)... Israel , May 31, 2016 ... its proprietary plant-based rhCollagen technology for tissue repair products ... Chief Scientist of Israel,s Ministry ... 12 million development project for 2016. The Chief Scientist,s grant ... year,s authorized grant, which totaled NIS 4.7 million.  ...
(Date:5/31/2016)... , May 31, 2016 ... research report with comparative analysis of Asthma therapy at ... action (MoA), route of administration (RoA) and molecule type, ... releases. It also reviews key players involved in the ... and discontinued projects. Complete report on H1 ...
Breaking Medicine Technology: